HC Wainwright & Co. reiterated coverage on AcelRx Pharmaceuticals with a new price target

8/17/21 6:22:04 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

HC Wainwright & Co. reiterated coverage of AcelRx Pharmaceuticals with a rating of Buy and set a new price target of $5.00 from $7.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$ACRX

Date	Price Target	Rating	Analyst
8/17/2021	$7.00 → $5.00	Buy	HC Wainwright & Co.